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Abstract
A major impediment to CNS repair is the glial scar, which forms following damage and is composed
mainly of ramiﬁed, ‘reactive’ astrocytes that inhibit neuronal regrowth. The transition of astrocytes
into this reactive phenotype (reactive gliosis) is a potential therapeutic target, but glial scar
formation has proved difﬁcult to study in monolayer cultures because they induce constitutive
astrocyte activation. Here we demonstrate a 3D collagen gel system in which primary rat astrocytes
were maintained in a persistently less reactive state than comparable cells in monolayer, resembling
their status in the undamaged CNS. Reactivity, proliferation and viability were monitored and
quantiﬁed using confocal, ﬂuorescence and time-lapse microscopy, 3D image analysis, RT–PCR
and ELISA. To assess the potential of this system as a model of reactive gliosis, astrocytes in 3D
were activated with TGFβ1 to a ramiﬁed, reactive phenotype (elevated GFAP, Aquaporin 4, CSPG,
Vimentin and IL-6 secretion). This provides a versatile system in which astrocytes can be maintained
in a resting state, then be triggered to undergo reactive gliosis, enabling real-time monitoring and
quantitative analysis throughout and providing a powerful new tool for research into CNS damage
and repair. Copyright  2009 John Wiley & Sons, Ltd.
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1. Introduction
Traumatic injuries to the brain and spinal cord are
debilitating and often lead to cognitive impairment,
paralysis and loss of sensation. Failure of the injured CNS
torepair isinpartattributedtotheinhibitoryenvironment
of the lesion site, most notably the formation of the
glial scar, which consists predominantly of astrocytes
and forms a physical and physiological barrier to axon
regeneration (Fawcett and Asher, 1999). Astrocytes
in the undamaged CNS express low levels of glial
ﬁbrillary acidic protein (GFAP) (Cancilla et al., 1992)
but, following injury, exhibit a reactive hypertrophic
phenotype (reactive gliosis) exempliﬁed by upregulation
of various markers, including GFAP, vimentin, aquaporin-
4 (AqP4), S100β and chondroitin sulphate protoglycans
(CSPGs) (Calvo et al., 1991; Hirsch and Bahr, 2000;
Silver and Miller, 2004; Saadoun et al., 2005; Neal et al.,
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2007). A common ﬁnding of strategies aimed at bridging
CNS lesions, particularly tissue-engineered approaches
using biomimetic materials (Phillips et al., 2004), is that
although axons readily enter and traverse the bridging
graft, they seldom exit the graft and re-enter the host
parenchyma, due to the inhibitory glial scar at the
graft–CNS interface (Geller and Fawcett, 2002).
Research in this ﬁeld often focuses on the physiology
of CNS injury in experimental animals. Using these
in vivo models is an essential stage in developing new
strategies for treating human CNS damage, but these
models are often too complex for the isolation and control
of speciﬁc variables and, when seeking to understand
cell-level biology, they allow only a snapshot view upon
post mortem examination. For many research questions
in neuroscience, in particular exploring the behaviour
of speciﬁc cell populations involved in damage and
repair or establishing mechanisms involved in glial
scar development and maturation, in vitro models can
provide a valuable tool. Commonly used in vitro models
of the glial scar have employed mechanical scraping
of two-dimensional (2D) astrocyte cultures to produce
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a‘ w o u n d ’( Y uet al., 1993), stretching of astrocytes
cultured on silastic membranes (Ellis et al., 1995; Wanner
et al., 2008) and creation of a glial scar in vivo on
nitrocellulose membranes that are removed and cultured
in vitro (McKeon et al., 1991). Whilst these and other 2D
culture models have revealed key information regarding
the reactivity of astrocytes and their effects on neuronal
growth(reviewed by(WuandSchwartz,1998)),thereare
limitations to their usefulness for studying the process of
reactive gliosis, since astrocytes in 2D cultures are highly
reactive, making it difﬁcult to monitor further activation.
Scientists in other areas of biology are increasingly
utilizing three-dimensional (3D) cell culture systems,
which allow researchers to investigate cell behaviour in
a more physiologically relevant state (Lee et al., 2008).
Furthermore, the glial scar is a 3D structure composed of
a meshwork of interwoven astrocytic processes that form
a barrier, which consequently is very difﬁcult to model
in 2D cultures (Fawcett et al., 1989). Tissue-engineered
3D culture models offer an exciting opportunity to ﬁll
the gulf in nervous system research between simple cell
culture systems and whole-animal models (Pampaloni
et al.,2007;Leeet al.,2008).Thesecanprovideavaluable
means to investigate cell biology, using highly controlled
environments in which parameters are easily manipulated
to gain insight into the fundamental biological processes
that follow nervous system injury whilst maintaining the
cells in a meaningful spatial arrangement.
The aim of this work was to develop a 3D culture
system in which astrocytes could be maintained in a less
reactive manner than in conventional monolayer culture.
For such a system to be useful, it would be reproducible,
controllable and amenable to a wide variety of analyses,
including immunocytochemistry, time-lapse and confocal
microscopy, ELISA and RT–PCR. Furthermore, astrocytes
would be capable of responding to a damage stimulus in
a manner similar to their in vivo counterparts (changes in
morphology, expression of proteins and release of soluble
factors).
To achieve these aims, type-I collagen was chosen
as the substrate of choice for 3D cultures, due to the
ease with which it can be controlled and manipulated
to enable versatile monitoring and imaging. It is a good
basal substrate that can be used as a scaffold on which
cells can deposit additional extracellular matrix (ECM)
molecules as they modify their 3D environment. This
is particularly important for investigating proteoglycan
synthesis by astrocytes in response to activation, which
would be difﬁcult to detect in more complex 3D culture
substrates (e.g. Matrigel), which often contain mixtures
of a wide range of ECM proteins from the outset.
To test the effectiveness of this approach, the viability
and activity of astrocytes in 3D collagen gels was
investigated, then they were treated with TGFβ1,
considered to be a likely trigger for astrogliosis in vivo
(Silver and Miller, 2004), causing astrocyte responses
typical of reactive gliosis. Thus we report a model in
which reactive gliosis can be controlled and monitored to
improve the development of CNS repair strategies.
2. Materials and methods
2.1. Primary cortical astrocyte cultures
All experiments were performed according to the
UK Animals (Scientiﬁc Procedures) Act (1986) and
approved by the appropriate institutional ethical com-
mittee. Sprague–Dawley rats were used from established
in-house breeding colonies. Primary astrocyte cultures
were prepared from the cortices of postnatal 2 day-old
rat pups (adapted from Dutton et al., 1981). Following
decapitation, the cortices were dissected out and the
meninges and associated blood vessels removed with ﬁne
forceps. The tissue was roughly chopped with a scalpel
blade, placed in 250 µg/ml trypsin in 10 ml disaggre-
gation medium [14 mM glucose (Sigma, Dorset, UK),
3 mg/ml bovine serum albumin (BSA; Sigma), 1.5 mM
MgSO4 ( B D H ,V W R ,U K )i nC a 2+-a n dM g 2+-free Earle’s
balanced salt solution (Gibco, Invitrogen, Paisley, UK)]
for 15 min at 37 ◦C, and agitated every few minutes. Fol-
lowing this incubation, a dilute solution of soya bean
trypsin inhibitor (21 µg/ml SBTI; Sigma) and deoxyri-
bonuclease 1 (6 µg/ml DNase; Sigma) was added and
the cell suspension was centrifuged for 2 min at 250 × g
to pellet the tissue. The supernatant was removed and
the pellet resuspended in 500 µl concentrated solution
of SBTI and DNase (133 µg/ml and 40 µg/ml, respec-
tively). The solution was triturated using a 1 ml pipette
to break down any larger clumps of tissue; a fur-
ther 500 µl concentrated SBTI and DNase solution was
added and the suspension left to settle for 2 min. The
material at the top of the suspension was removed to
a separate 15 ml tube. This trituration procedure was
repeated twice more. The resulting cell suspension was
then underlain with 4% w/v BSA, which was then
centrifuged at 250 × g for 5 min. The supernatant was
gently removed and the pellet resuspended in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Gibco) supplemented
with penicillin/streptomycin (100 U/ml and 100 µg/ml
respectively; Sigma) and with 10% v/v fetal calf serum
(FCS). This suspension was dispensed into 75 cm2 ﬂasks
(Greiner, Stonehouse, UK) that had been coated with
poly-D-lysine (Sigma) at an approximate density of 1–2
cortices/ﬂask.Eachﬂaskwastoppedupwith20 mlDMEM
and placed in a humidiﬁed incubator at 37 ◦Cw i t h5 %
CO2:95% air.
2.2. 2D and 3D astrocyte cultures
Astrocytes were expanded in culture for 8 days to reach
conﬂuence. The ﬂasks were shaken at 150 rpm for 4 h
to deplete the microglia and less adherent cells from
the cultures. Following shaking, the resulting cultures
were 95% astrocytes (as determined by immunoreactivity
for GFAP and IB4 lectin). The medium was removed
and 7 ml trypsin–EDTA solution (Sigma) was added
to each ﬂask for 15 min at 37 ◦C. The trypsin was
neutralized by the addition of 13 ml DMEM/ﬂask,
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supplemented with penicillin/streptomycin and 10% FCS.
The cells were centrifuged at 250 × g for 5 min and
the pellet resuspended in 1 ml medium; the cells were
counted using a haemocytometer. For 2D astrocyte
cultures, coverslips were coated with 15 µgt y p eI
rat tail collagen (First Link UK Ltd, Birmingham,
UK) in 0.6% acetic acid for 1 h. This solution was
removed and the coverslips were then rinsed with
sterile phosphate-buffered saline (PBS) to removed
any traces of acid, then were left to dry at room
temperature. 35 K astrocytes were plated in 100 µl
suspension per collagen-coated coverslip in multiwell
plates and left to adhere for 1 h at 37 ◦C before adding
2 ml DMEM supplemented with penicillin/streptomycin
10% FCS/well.
For 3D astrocyte cultures, cells were seeded at a density
of 2 million cells/ml gel. The gels were composed of 10%
cell suspension in DMEM, 10% 10× minimum essential
medium (MEM; Sigma) and 80% type-I rat tail collagen
(2 mg/ml in 0.6% acetic acid; First Link, UK). The
MEM and collagen were mixed together and neutralized
using sodium hydroxide, assessed by colour change of
phenol red. Upon neutralization, the collagen–MEM
mixture was gently mixed with the cell suspension and
transferred to 24-well plates (0.75 ml/well; resulting
gels approximately 4 mm thick) before placing at 37 ◦C
to set (∼5 min). Once the gels had set, the wells
were topped up with 2 ml DMEM supplemented with
penicillin/streptomycin and 10% FCS. Coverslips and
gels for experiments comparing 2D and 3D conditions
were maintained in culture for 24 h before ﬁxing or RNA
extraction.
2.3. Cell viability and proliferation
Cell viability was assessed using propidium iodide (PI;
Sigma) staining in combination with Hoechst. Brieﬂy, PI
wasaddedtoculturesat200 µg/mlincell culturemedium
and left to incubate for 10 min at 37 ◦C. The medium was
then removed and the cultures were rinsed in PBS before
ﬁxing in 4% paraformaldehyde (PFA) at 4 ◦C. Gels and
coverslips were incubated with Hoechst 33258 (1 µg/ml;
Sigma) in PBS for 10 min, before 3 × 5 min washes in
PBS. Bromodeoxyuridine (BrdU) incorporation was used
to assess cell proliferation in addition to cell counts.
BrdU was added into cell culture medium at 10 µM
and incubated at 37 ◦Cf o r2 0 m i n .T h ec u l t u r e sw e r e
washed twice with DMEM, then PBS, before ﬁxing in 4%
PFA. For BrdU only, coverslips and gels were incubated
with 0.5% Triton-X-100 to permeabilize the cells before
treating with DNase at 37 ◦C for 1 h. Detection of BrdU
was performed as described in the Immunocytochemistry
section below. The number of dead or proliferating cells
was calculated as a percentage of the total number of cells
per ﬁeld (three randomly selected ﬁelds per coverslip or
gel).
2.4. RT–PCR
Total RNA was isolated from primary astrocytes using
Trizol (Invitrogen). For 2D cultures, the medium was
removed and Trizol was added directly onto the cells.
The cells were then scraped and the resulting solution
collected into sterile 2 ml tubes. The medium was
removed from 3D gels; following a wash in sterile PBS,
each gel was added to a sterile 2ml tube containing
1 ml Trizol, which was then frozen in liquid nitrogen.
After thawing, the gels were homogenized in the Trizol
by trituration with a 19 G hypodermic needle on a
syringe until no lumps of collagen gel were remaining.
RNA extraction was then carried out according to the
manufacturer’s instructions. The yield of total RNA was
quantiﬁed by optical density (OD) readings at 260 nm,
and the purity was estimated by the 260:280 nm ratio.
Equivalent amounts of total RNA (3 µg) from astro-
cyte preparations were reverse-transcribed into single-
stranded cDNA in a reaction mixture containing 10 mM
dithiothreitol, 40 U RNase inhibitor, 10 mM Tris–HCl, pH
8.3, 15 mM KCl, 0.6 mM MgCl2,0 . 5m M dNTPs, 250 ng
random primers and 600 U MMLV reverse transcriptase
(Invitrogen) at 37 ◦C for 80 min. Incubation for 10 min at
70 ◦C terminated the reverse transcription reaction. Neg-
ative controls were prepared by incubation of samples
without reverse transcriptase.
PCR was performed on the equivalent of 100 ng
reverse-transcribed total RNA from each sample. A ther-
mocycler was used with a reaction mixture containing
50 mM KCl, 10 mM Tris–HCl, pH 9, 0.1% Triton X-100,
0.5 mM MgCl2, 200 µM dNTPs, 1 µM each upstream and
downstream primer, and 2.5 U TaqDNA polymerase
(Invitrogen). MgCl2 concentrations and optimal anneal-
ing temperatures (OAT) were as follows: (1) GFAP (McK-
eon et al., 1999), 1.5 mM MgCl2,O A T6 0 ◦C, 20 cycles,
forward 5 -GCCGCTCCTATGCCTCCTCCGA-3 , reverse
5 -TCCAGCGACTCAACCTTCCTCT-3 ;(2)GAPDH(Copel-
man et al., 2000), 2 mM MgCl2,O A T6 0◦C, 25 cycles, for-
ward 5 -TGGTGCCAAAAGGGTCATCATCTCC-3 , reverse
5 -GCCAGCCCCAGCATCAAAGGTG-3 ;( 3 )N e u r o c a n( Q i
et al., 2003), 1.5 mM MgCl2,O A T6 0 ◦C, 20 cycles,
forward 5 -CTGCTTCTTTACCCTTCAACCAC-3 , reverse
5 -AGTTGTCAAAGCCATCTTCGAAC-3 . Primer pairs
spanned an exon boundary to obviate DNase treatment
of total RNA before reverse transcription (RT)–PCR. PCR
performed on non-reverse-transcribed total RNA samples
did not produce any detectable products. The thermal
cycle proﬁle for each set of primers included a primary
denaturation cycle at 94 ◦C for 5 min and a ﬁnal exten-
sion period at 72 ◦C for 10 min. The intervening PCR
cycle consisted of 45 s segments of primer denaturation,
annealing and extension.
Equivalent amounts (12 µl) of each PCR product were
size-fractionated on a 1% agarose gel and the product
size was veriﬁed by running the samples against a 100
bp DNA ladder (Promega, Southampton, UK). The PCR
products were visualized by staining the agarose gels
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with 0.5 µg/ml ethidium bromide and viewing under
ultraviolet light.
2.5. Time-lapse microscopy
Imaging was performed using an Olympus IX70 inverted
microscope with heated stage set at 37 ◦Ca n da2 0 ×
viewing objective. Images were captured using In Vivo 3
software (Media Cybernectics, MD, USA), then processed
using Volocity image analysis software (Improvision,
Perkin-Elmer, Coventry, UK). For time-lapse microscopy,
2D and 3D astrocyte cultures were prepared as described
above. Cells were plated onto collagen-coated coverslips
or seeded into collagen gels and were viewed for 24 h,
with images taken every 10 min. The cultures were kept
in CO2-independent medium (Gibco) for the duration of
the time-lapse experiment.
2.6. Astrogliosis model
3D astrocyte gels were treated with transforming
growth factor-β1( T G F β1; 10 ng/ml; R&D Systems,
Abingdon, UK), diluted in DMEM supplemented with
penicillin/streptomycin and 10% FCS every other day
for 15 days. TGFβ1 has previously been used as a positive
reactivity control(Cullen et al.,2007)andinducesspeciﬁc
alterations that are consistent with astrogliosis (Logan
et al., 1994). Furthermore, TGFβ1 has been identiﬁed
as one of the potential triggers of inhibitory astrogliosis
(Silver and Miller, 2004). Control gels were subject to
media change only on the same days. Supernatants
werecollected throughouttheexperimentsforsubsequent
analysis of cytokines and gels were ﬁxed at days 1, 5, 10
and 15 throughout the experiment.
2.7. Immunocytochemistry
The same procedure for immunocytochemistry was
performed on coverslips and gels, with the incubation
and wash times increased for gels. After ﬁxing, the gels
were cut into quarters for staining and image analysis.
Cell permeabilization was performed using 0.5% Triton-
X-100 (Sigma), 15 min for coverslips, 30 min for gels.
Following 3 × 5 min washes, non-speciﬁc binding was
blocked with 5% normal swine serum (Dako, Ely, UK)
in PBS for 20 min (coverslips) or 40 min (gels). After
anotherwashstep,primaryantibodiesweredilutedinPBS
(Table 1) and incubated at room temperature for 1.5 h
(coverslips) or overnight at 4 ◦C (gels). Following 3 × 10
min washes, secondary antibodies [anti-rabbit ﬂuorescein
isothiocyanate (FITC), anti-rabbit tetramethylrhodamine
isothiocyanate (TRITC), anti-mouse FITC or anti-mouse
TRITC (Sigma)] were diluted in PBS (1 in 100) and
added for 45 min (coverslips) or 1.5 h (gels). Hoechst
33258 (1 µg/ml) was also added into the secondary
antibody dilutions for cell counting. Omission of primary
or secondary antibody was routinely used as a control.
Coverslips were placed on slides in ﬂuorescence mounting
medium (Dako) and sealed with nail varnish. Gels were
stored in PBS.
2.8. Image analysis and quantification
Fluorescence microscopy was performed on coverslips
and gels for comparison between 2D and 3D cultures.
Imageswere capturedusinganOlympusBX61microscope
with Analysis Pro imaging software (Olympus Soft
Imaging System, M¨ unster, Germany). Three ﬁelds were
randomly selected per coverslip or gel. The number of
immunopositive cells was calculated as a percentage of
the total number of cells/ﬁeld. In addition, the average
number of cells/ﬁeld was compared between astrocytes
in gels for 1 and 24 h as another indication of cell
proliferation.
Confocal microscopy (Leica DMIRBE, Leica Microsys-
tems, Mannheim, Germany) was performed on control
gels and gels treated with TGFβ1 and images were cap-
tured using Leica confocal software (Leica, Germany);
each ﬁeld measured 1 × 1m m× 40 µm( xyz), with
40 slices/stack in the Z dimension. Analysis included
14 independent gels per time point (seven control
and seven TGFβ1), from two separate cell prepara-
tions. Three ﬁelds per gel quarter were selected accord-
ing to a robust protocol (2 mm in from all edges in
a triangular formation). The perimeter of cell stain-
ing (GFAP, AqP4, Vimentin) and the area of staining
(CS56) were calculated using Volocity image analysis
software (Improvision, Perkin-Elmer). Automated anal-
ysis protocols were developed by identifying cells by
intensity of staining, so various measurements could be
calculated.
Cell shape was analysed using Openlab (Improvision)
software. Extended-focus GFAP images captured by
confocal microscopy were analysed, with three ﬁelds per
gel and seven gels per time point per condition (i.e.
control and TGFβ1 treatment). The formula utilized for
this analysis by the software is (4 × π × A)/P2,w h e r e
A is the cell area and P is the cell perimeter. A
perfectly spherical cell will have a value of 1, whilst
smaller values indicate progressively more irregularly
shaped cells, thus providing an indicator of how rounded
or ramiﬁed (i.e. with branch-like processes) the cells
were.
Table 1. Primary antibodies used in immunocytochemistry
Primary
antibody Dilution Source
BrdU 1 in 500 Abcam clone BU1/75
GFAP 1 in 300 Dako
Vimentin 1 in 50 Sigma clone V9
CSPGs 1 in 100 Sigma clone CS-56
AqP4 1 in 300 Chemicon
S100β 1 in 1000 Dako
β-Actin 1 in 200 Sigma clone AC15
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Figure 1. Astrocytes in 3D collagen gels have lower expression of activation markers. (a) Immunoﬂuorescent staining for activation
markers GFAP (A + B), CS56 (C + D), aquaporin 4 (E + F), vimentin (G + H) and S100β (I + J) were compared in 2D astrocyte
cultures on collagen-coated coverslips and in 3D collagen gels. Staining for β-actin (K + L) was used as a positive control. Hoechst
33258 was used to detect cell nuclei. Scale bar = 100 µm. (b) Staining for all activation markers was signiﬁcantly decreased on
astrocytes in 3D collagen gels compared to astrocytes in 2D cultures. Staining for β-actin was comparable for both 2D and 3D
astrocyte cultures (data are mean ± SEM; n = 7; ∗∗∗p < 0.001). (c) RT–PCR showed lower levels of mRNA for GFAP and neurocan
in astrocytes from 3D collagen gel cultures when compared to astrocytes grown in monolayers. Representative samples shown
2.9. Enzyme-linked immunosorbant assay
(ELISA) for interleukin 6 (IL-6)
A quantitative sandwich ELISA for IL-6 (R&D Systems)
was carried out according to the manufacturer’s instruc-
tions. Brieﬂy, a standard curve for rat IL-6 was prepared
(range 0–4000 pg/ml). 50 µl standard, sample (cell cul-
ture supernatant), blank or positive control were added
to a 96-well plate precoated with rat-speciﬁc IL-6 capture
antibody. After incubation for 2 h at room temperature,
the plate was washed and the horseradish peroxidise-
conjugated detection antibody was incubated for 2 h at
room temperature. Following further washing, a tetram-
ethlybenzidine substrate solution was added to the wells
andincubatedfor30 minatroomtemperatureinthedark.
The enzyme reaction was stopped using dilute hydrochlo-
ric acid and the OD of each well was read at 450 nm, with
reference reading at 570 nm.
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2.10. Statistical analysis
Data were analysed with the GraphPad Prism computer
package (GraphPad Software, San Diego, CA, USA).
Normality and quality of variance tests were performed
on all data to determine which test was appropriate. A
t-test was used, with signiﬁcance level set at 95% for
comparison between 2D and 3D culture datasets and to
compare between control and TGFβ1-treated cultures
at each of the time points. If variances of datasets
were signiﬁcantly different, then Welch’s correction was
applied. A one-way ANOVA with Dunnett’s multiple
comparison post hoc test was performed to compare
control data points over the 15 day experimental period.
All values are indicated as the mean ± standard error of
the mean (SEM). p v a l u e sw e r et a k e na sa ni n d i c a t o ro f
statistical signiﬁcance, using the following nomenclature:
∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001.
3. Results
3.1. Astrocytes in 3D cultures are constitutively
less activated than in 2D
Astrocytes on collagen-coated coverslips (2D) or in col-
lagen gels (3D) were compared for immunoﬂuorescence
staining (Figure 1a) of the activation markers GFAP (A
+ B), CSPGs (C + D), AqP4 (E + F), vimentin (G +
H) and S100β (I + J) after 24 h in culture. The num-
ber of astrocytes immunopositive for all of the activation
markers in 3D cultures were signiﬁcantly fewer when
compared to astrocytes grown on 2D monolayer cultures
(Figure 1b; p < 0.001). To conﬁrm that this result was
not due to differences in staining protocol or reduced
diffusion of antibodies through the gels, staining for β-
actin was carried out as a positive control (Figure 1a;
K + L). The number of β-actin-immunopositive astro-
cytes did not differ signiﬁcantly between 2D and 3D
cultures, thus indicating that the differences in the activ-
ity markers was due to astrocytes in 3D gels exhibit-
ing a less reactive phenotype than those in 2D, after
24 h.
In order to investigate whether mRNA levels of GFAP
and an astrocyte-speciﬁc CSPG, neurocan, were affected
bychangesincellculturedimension,inadditiontoprotein
levels, RT–PCR was performed for these markers and
compared to the house-keeping gene GAPDH. Message
levels for neurocan and more notably GFAP were reduced
in astrocytes cultured in 3D collagen gels, compared to
those grown in 2D monolayers (Figure 1c).
3.2. Cell viability and proliferation
Staining for PI and BrdU incorporation was used as
a way of determining cell death and proliferation in
2D and 3D astrocyte cultures. The percentage of PI-
positive and BrdU-positive cells was signiﬁcantly greater
in astrocytes cultured in 3D collagen gels than those
growing on coverslips after 24 h (Figure 2a; p < 0.05
and p < 0.001, respectively). To determine the extent of
astrocyte proliferation in 3D culture over 24 h, astrocytes
were seeded into collagen gels and left for 1 and 24 h,
then the total numbers of cells/ﬁeld were calculated. The
number of cells did not signiﬁcantly change between 1
and 24 h in culture, suggesting no astrocyte proliferation
(Figure 2b). Thus, the BrdU-positive cells observed after
24 h could indicate cells that had undergone S-phase but
not yet progressed through G2 and M phases prior to
cell division. The 2D PI data may not truly represent
cell death, since dead cells in monolayer culture tend to
ﬂoat off the coverslips into the medium. Nevertheless,
small differences in cell death and/or proliferation
between the culture dimensions cannot entirely account
for the large differences observed in activation markers in
Figure 1c.
Figure 2. Cell death and proliferation in 2D and 3D astrocyte
cultures. (a) Cell death and proliferation of astrocytes was
compared between 2D and 3D cultures using PI staining and
BrdU incorporation at a 24 h time point. The number of cells
immunopositive for PI and BrdU was signiﬁcantly higher in
astrocytes in 3D collagen gels than those on collagen-coated
coverslips. (b) The total number of astrocytes per ﬁeld after 1 h
and 24 h did not differ signiﬁcantly (data are mean ± SEM;
n = 4; ∗p < 0.05, ∗∗∗p < 0.001)
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Figure 3. Time-lapse imaging of the initial 24 h of 2D and 3D astrocyte cultures. Astrocytes were seeded onto coverslips or into
collagen gels and were imaged using time-lapse microscopy for the initial 24 h in culture. Images were taken every 10 min;
representative images are shown from 0, 3, 6, 9, 12, 15, 18, 21 and 24 h time points (see Supporting information for two time-lapse
movies). The key differences observed were that cells in 2D had larger cell area and ﬂattened morphology (arrowheads) with wider
ﬁlopodia (arrows) compared to astrocytes in 3D. Astrocytes in 3D extended ﬁne ﬁlopodia (arrows) and migrated through the gel,
but were generally rounder and had a smaller cell area (arrowheads). Scale bar = 100 µm
3.3. Time-lapse microscopy – differences in cell
morphology and motility between 2D and 3D
astrocyte cultures
One of the major beneﬁts to in vitro approaches is the
ability to monitor cells in real time. To investigate
the behaviour of astrocytes in our 3D collagen gel
system, cultures were subject to time-lapse microscopy
over the initial 24 h following seeding and compared
to conventional 2D astrocyte cultures. Representative
images from 3 h time periods are shown in Figure 3 and
two time-lapse movies are available in the Supporting
information. Astrocytes in 2D monolayer spread and
migrated over the initial 24 h in culture. In general, these
astrocytes had larger cell area and ﬂattened morphology
(Figure 3, arrowheads, 2D; 9, 18 and 24 h), with wider
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Figure 4. Perimeter of astrocytic GFAP staining increases with TGFβ1-treatment. (a) Representative extended focus confocal
images of control (A–D) and TGFβ1-treated (E–H) astrocytes over 15 days in culture stained for GFAP. Scale bar = 200 µm.
(b) Quantiﬁcation of GFAP staining showed that cell perimeters signiﬁcantly increased in TGFβ1-treated astrocytes from 5 days in
culture compared to non-treated control cultures at the same time point. Data are mean ± SEM normalized to cell number (n = 7;
∗p < 0.05). (c) Shape analysis of GFAP-positive cells, whereby values close to 1 represent perfect circular cells and values < 1
indicate irregular, ramiﬁed cells. Cells from TGFβ1-treated cultures were signiﬁcantly more ramiﬁed than controls after 5, 10 and
15 days in culture (n = 7; ∗∗p < 0.01, ∗∗∗p < 0.001)
ﬁlopodia (Figure 3, arrows, 2D; 3, 6 and 21 h) compared
to astrocytes in 3D. Astrocytes in 3D extended thin
ﬁlopodia that could project over distances up to 400 µm
(Figure 3, arrows, 3D; 0, 12 and 24 h). Furthermore,
astrocytes in 3D cultures were able to migrate easily
through the gel matrix but appeared more round in shape
and smaller than astrocytes in 2D cultures (Figure 3,
arrowheads, 3D; 0, 6 and 21 h).
3.4. Induction of astrogliosis by TGFβ1
treatment
TGFβ1 has been identiﬁed as one of the potential
triggers of inhibitory glial scar formation following
spinal cord injury (Silver and Miller, 2004) and it has
previously been shown to induce speciﬁc alterations in
astrocytes that are consistent with gliosis (Logan et al.,
1994). Following CNS injury in vivo, acute upregulation
of TGFβ1 is detected within neurons, astrocytes and
invading macrophages, and can additionally be found in
astrocytesupto1 yearfollowinginjury(Busset al.,2008),
suggesting a role in the formation and maintenance of
the glial scar. Treatment of 3D astrocyte cultures with
TGFβ1 for a 15 day period was utilized to recreate
some aspects of a CNS injury environment. In vivo,
the mature glial scar takes approximately 2 weeks to
form, hence the 15 day time frame for this experiment.
Analysis of immunoﬂuorescence staining for GFAP,
CSPGs, vimentin and AqP4 was performed to determine
the extent of astrocyte activation. Staining for GFAP,
vimentin and AqP4 revealed that control untreated
cells over 15 days in culture showed very little change
in morphology (Figures 4a, A–D; 6a, A–D; 7a, A–D).
In addition, staining for CS56 revealed that there
was very little change in expression and deposition
of CSPGs in control untreated cultures over 15 days
(Figure 5a A–D). However, with increasing time of
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Figure 5. Area of astrocytic CSPG staining increases with TGFβ1-treatment. (a) Representative extended focus confocal images
of control (A–D) and TGFβ1-treated (E–H) astrocytes over 15 days in culture stained for CS56, showing cell-associated staining
and CSPG deposited by cells into the surrounding extracellular matrix. Scale bar = 200 µm. (b) Quantiﬁcation of CSPG expression
showed that area of staining signiﬁcantly increased in TGFβ1-treated astrocytes after 15 days in culture compared to non-treated
control cultures at the same time point (data are mean ± SEM normalized to cell number; n = 7; ∗∗∗p < 0.001)
TGFβ1-treatment, astrocytes appeared considerably more
ramiﬁed compared to control cultures at the same time
points when stained for GFAP, vimentin and AqP4
(Figures 4a, E–H; 6a, E–H; 7a, E–H) and there was
more cell-associated CSPG staining and at day 15 more
deposition of CSPGs in the gels (Figure 5a, E–H).
Quantiﬁcation of changes in GFAP, vimentin and AqP4-
positive cell morphology was assessed by measuring cell
perimeter on extended-focus confocal micrographs. The
area of staining was analysed for CS56 to determine
cell-associated CSPG staining and that deposited by cells
into the surrounding ECM. All data were normalized to
the number of cells/ﬁeld in order to correct for any
potential cell proliferation over the 15 day time period
of the experiment. The perimeter of GFAP, vimentin
and AqP4 staining or the area of CS56 deposition did
not signiﬁcantly change in samples from non-treated
control gels over the 15 days (Figures 4b, 5b, 6b, 7b).
In astrocyte gels treated with TGFβ1, the perimeter of
GFAP staining signiﬁcantly increased at days 5, 10 and 15
(Figure 4b; p < 0.05), representative of the hypertrophy
and ramiﬁcation of these cells following treatment with
TGFβ1. The area of CSPG staining increased signiﬁcantly
at day 15 in TGFβ1-treated astrocyte cultures (Figure 5b;
p < 0.001), representative of the increased synthesis and
release of CSPGs. The perimeter of vimentin staining
signiﬁcantly increased in TGFβ1-treated astrocytes after
5 days in culture, compared to non-treated control
cultures at the same time point (Figure 6b; p < 0.05),
although increases were seen at days 10 and 15, these
did not reach statistical signiﬁcance. In astrocyte gels
treated with TGFβ1, the perimeter of AqP4 staining
signiﬁcantly increased at 5, 10 and 15 days (Figure 7b;
p < 0.001, p < 0.01 and p < 0.05, respectively), again
indicating a high degree of hypertrophy and ramiﬁcation
of these cells following cytokine treatment. The area
of staining for GFAP, vimentin and AqP4 showed a
similar pattern to perimeter measurements (data not
shown).
Analysis of cell shape was performed on images
from control and TGFβ1-treated astrocyte gels stained
for GFAP. Cells that are circular have a value close
to 1, whereas irregularly shaped cells have smaller
values. Cell shape did not signiﬁcantly differ between
control cultures over the 15 day experiment (Figure 4c).
However, GFAP-positive cells did become signiﬁcantly
more ramiﬁed (less circular) over time in TGFβ1-treated
astrocyte cultures, compared to controls at the same time
point (Figure 4c; p < 0.01 day 5, p < 0.001 day 10, and
p < 0.0001 day 15).
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Figure 6. Perimeter of astrocytic vimentin staining increases with TGFβ1 treatment. (a) Representative extended focus confocal
images of control (A–D) and TGFβ1-treated (E–H) astrocytes over 15 days in culture, stained for vimentin. Scale bar = 200 µm.
(b) Quantiﬁcation of vimentin staining showed that cell perimeter signiﬁcantly increased in TGFβ1-treated astrocytes at 5 days in
culture compared to non-treated control cultures at the same time point; although increases were seen at 10 and 15 days, these
did not reach statistical signiﬁcance (data are mean ± SEM normalized to cell number; n = 7; ∗p < 0.05)
3.5. Release of IL-6 by activated astrocytes
A key source of IL-6 in the injured spinal cord is astrocytes
and its release is characteristic of their activation (Norris
et al., 1994; Van Wagoner and Benveniste, 1999; Farina
et al., 2007). IL-6 release from astrocytes was measured
by ELISA of cell culture supernatants. Protein analysis
revealed comparable levels of protein in all supernatant
samples, thus normalization to protein content was not
required and did not change the results. Levels of IL-
6 release from control non-treated astrocytes decreased
over time (Figure 8) and was signiﬁcantly less at day 15
compared to day 1 in culture (p < 0.01). IL-6 release
from TGFβ1-treated astrocytes decreased after 5 days in
culturebutincreasedagainafter10and15 days.Atday15
levels were signiﬁcantly higher than controls (p < 0.001;
Figure 8).
4. Discussion
Here we report the development of a 3D in vitro model
of astrogliosis that mimics many features of the glial
scar environment within the CNS. Changing the cell
culture dimension from conventional 2D monolayer
to a 3D setting leads to downregulation of astrocyte
activation markers, indicating that astrocytes in 3D are
less reactive than their 2D counterparts, thus resembling
the physiological in vivo situation and providing the ﬁrst
‘ground state’ system in which triggers of astrogliosis
can be investigated. This was validated using TGFβ1
treatment over 15 days, during which astrocytes adopted
characteristics of the mature glial scar, with changes in
cell morphology, expression of activation markers and
secretion of cytokines associated with activation.
Substantial differences in gene and protein expression
were observed in this study between 2D and 3D cultures,
which is the ﬁrst to undertake such a comparison
using primary astrocytes. The 3D culture environment
surrounds cells with ECM, providing nutritional and
structural support from all directions, contrasting with
a 2D environment where cells adhere on one side and
receive nutrition from the other. Furthermore, cells adopt
less constrained shapes in 3D gels, whereas in 2D culture
t h e ya r ef o r c e dt oa d j u s tt oaﬂ a ts u r f a c e( L e eet al.,
2008). Differences between other cell types in 2D and 3D
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Figure 7. Perimeter of astrocytic aquaporin 4 staining increases with TGFβ1-treatment. (a) Representative extended focus confocal
images of control (A–D) and TGFβ1-treated (E–H) astrocytes over 15 days in culture stained for AqP4. Scale bar = 200 µm.
(b) Quantiﬁcation of AqP4 staining showed that cell perimeter signiﬁcantly increased in TGFβ1-treated astrocytes from 5 days in
culture compared to non-treated control cultures at the same time point (data are mean ± SEM normalized to cell number; n = 7;
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001)
environments have been noted, associated in particular
with cell morphology and gene and protein expression
(Pedersen and Swartz, 2005). A comprehensive study
using neuroblastoma cells identiﬁed 1766 genes that
were signiﬁcantly differentially expressed between 3D
and 2D culture (regardless of whether collagen or
matrigel was the substrate), including those involved
in cytoskeletal reorganization, ECM, metabolism and
signalling (Li et al., 2007), thus highlighting the impact
of cell culture substrate geometry. In addition to spatial
constraints, differences observed between 2D and 3D
cultures are likely to reﬂect differences in mechanical
cues, particularly stiffness of the matrix. Physical and
mechanical cues are known to affect a multitude of
cell functions, such as adhesion, proliferation, migration,
differentiation and morphology (Li and Hoffman-Kim,
2008). In particular, stiffness sensing in astrocytes has
been reported, with cells on soft gels showing small and
round morphologies, similar to those seen in our 3D
experiments, with few stress ﬁbres. In contrast, on stiffer
gel surfaces astrocytes showed signiﬁcantly increased cell
area, with highly spread morphologies and more stress
actin ﬁbres, typical of reactive cultured glia (Georges
et al., 2006) and similar to astrocytes seen in conventional
2D monolayer cultures. In our system, astrocytes at the
edges of 3D cultures, where they were in contact with the
stiff plastic, showed elevated GFAP levels and appeared
more ramiﬁed, consistent with this previous suggestion
that substrate stiffness increases astrocyte reactivity.
The glial scar in vivo is a chemical and physical barrier,
involving soluble factors released by cells, molecules
expressed on the surface of cells, changes in ECM
composition and changes in the shape and size of the
various cells involved (Silver and Miller, 2004; Yiu and
He, 2006; Fitch and Silver, 2008). In terms of timing, cell
morphology and expression of markers, the response of
astrocytes to TGFβ1 treatment in our 3D system is similar
to that seen in vivo. This suggests that TGFβ1a l o n ec a nb e
sufﬁcient to induce astrogliosis, without the requirement
of other cellular components or paracrine effects. This
system also lends itself to analysis of cytokine secretion
from astrocytes. Astrocytes are a key source of IL-6 in
the injured spinal cord and its release is characteristic of
their activation. It is unlikely in this model that IL-6 will
positively feed back to initiate further astrocyte activation,
since this would require the presence of the soluble IL-6
receptor, not produced by these cells (Van Wagoner and
Benveniste, 1999; Van Wagoner et al., 1999).
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Figure 8. IL-6 release by astrocytes in 3D collagen gels. IL-6
was measured by ELISA of cell culture supernatants of control
and TGFβ-1 treated astrocyte gel cultures at 1, 5, 10 and
15 days. IL-6 released from control cultures decreased over
time, with a signiﬁcant reduction detected after 15 days in
culture (p < 0.01). IL-6 release from TGFβ1-treated astrocytes
decreased at 5 days in culture, but then increased again over
timeand wassigniﬁcantly higherthancontrolculturesat 15 days
(data are mean ± SEM; n = 5; ∗∗∗p < 0.001)
There are several cell culture models that have
attempted to recreate the complex environment of the
adult CNS, speciﬁcally glial scar, in three dimensions. One
of the ﬁrst was by Fawcett et al. (1989), who investigated
the growth of axons in cultures created by packing
astrocytesorSchwanncellsinto0.5 mmi.d.celluloseester
tubes,theninvestigatingtheinhibitionofneuronalgrowth
in the 3D astrocyte environment. It is important to use 3D
culture models to investigate the inhibition of neuronal
growth, since in monolayers neurons are able to grow
over the top of astrocyte cultures (Sorensen et al., 2007).
However, one potential drawback of the tube approach
for modelling astrocyte behaviour is that, since cells are
in contact with the curved 2D surface inside the tube,
they are constrained from adopting a true 3D phenotype.
Hydrogel systems are thus more appropriate for many
situations because they create a 3D microenvironment in
which cells are not subjected to mechanical cues, such
as those that exist on the inner surfaces of tubes or
within the pores of stiff scaffold materials (Brown and
Phillips, 2007; East and Phillips, 2008). Furthermore,
they enable mechanical cues to be isolated from chemical
cues,in order toexplore theireffects oncells (Cullen et al.,
2007) and provide an intermediate degree of complexity
between in vivo studies and 2D in vitro systems.
In summary, the present study ﬁrst investigated
differences between 2D and 3D primary astrocyte cultures
and then, by exploiting the observation that astrocytes in
3D are less reactive than their monolayer counterparts,
a system for investigating reactive astrogliosis was
developed. This system recreated the key features
of the response of astrocytes in the CNS following
damage and has been shown to support a wide range
of analytical techniques, including immunoﬂuorescence
image analysis, RT–PCR, time-lapse microscopy and
ELISA. By further developing the system to incorporate
multiple cell types, ECM molecules and mechanical
response investigations, our future aim is to utilize
this model as an in vitro test-bed in order to improve
tissue-engineered CNS repair devices. Revealing the
characteristics of astrocytes in this system provides new
tools and opportunities for neuroscientists to explore the
cell biology underlying in vivo observations, informing the
development of a new generation of models that combine
the accessibility of cell culture with the relevant spatial
environment of living tissue.
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